Latest News
FDA/CDC
ACIP plans flu review for older adults
Work group will address issues of which flu vaccine options may be best for seniors.
FDA/CDC
ACIP recommends two options for pertussis vaccination
Updated language allows use of either Tdap or Td for pertussis booster, prophylaxis, and catch-up immunization, according to ACIP recommendations...
News
Clinical interventions for global drug use need updating
Illicit drug use patterns around the world are changing rapidly, but interventions aimed at reducing harm are not keeping up with evidence.
News
New test edges closer to rapid, accurate ID of active TB
The blood-based triage test, which relies upon four host proteins and one TB antigen, is another step closer toward standards proposed by the WHO...
News
Hematopoietic cell transplant offers realistic cure in secondary AML
The observational trial showed that survival was significantly higher with transplant than with chemotherapy consolidation therapy in patients...
News
FDA approves Trikafta for treatment of cystic fibrosis
This drug makes treatment available to most cystic fibrosis patients, including adolescents.
News
Drug crisis continues to evolve beyond opioids
Primary care physicians “are well intentioned but underprepared and may miss some of the drug misuse risks affecting their patients,” says the...
News
Updated international consensus recommendations on management of acute upper GI bleeding
Updated guidelines on management of nonvariceal acute upper GI bleeding address questions on endoscopic techniques and pharmacologic management....
Conference Coverage
Race mismatch may affect survival in lung transplant setting
NEW ORLEANS – If it’s an option, clinicians should consider donor-to-recipient race compatibility.
Latest News
Dapagliflozin approved for reducing HF hospitalization in diabetes
It is the first SGLT2 inhibitor approved in the United States for this indication in adults with type 2 disease.